Surface Plasmon Resonance Market Growth Accelerated by Increased Adoption in New Applications
Surface plasmon resonance is a technique used for studying the kinetics of biochemical interactions between biomolecules such as antigen-antibody binding, protein-DNA binding, and protein-protein binding. It enables real-time analysis of biomolecular interactions without the use of labels. The technique provides details about binding affinity and kinetics of molecular interactions through the use of chip-based technology. The global Surface Plasmon Resonance Market is estimated to be valued at US$ 976.1 Mn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increased adoption of SPR in new applications such as diagnostics, drug
discovery, and food safety has emerged as a key trend fueling the growth of the
surface plasmon resonance market over the forecast period. SPR allows for
label-free detection of biomolecular interactions in real-time, serving as a
valuable screening tool in the development of novel drugs and assays.
Furthermore, the technique offers a viable alternative to radioisotope-based
detection, which has contributed significantly to its increased adoption in
diagnostics applications. The high sensitivity, real-time measurement
capabilities and minimal sample requirements associated with SPR have
positioned it as an indispensable tool in modern life sciences research and
development.
Segment
Analysis
The global Surface Plasmon Resonance (SPR) market is segmented into instrument
type, application and end user. Based on instrument type, the biosensor segment
dominates the market due to its high precision in detection of molecular
binding events. SPR biosensors provide real-time detection of biomolecular
interaction which has increased its adoption in pharmaceutical and
biotechnology companies for drug discovery applications.
Key Takeaways
The global Surface Plasmon Resonance market is expected to witness high growth.
Key players operating in the Surface Plasmon Resonance market are Bio-Rad Laboratories, Inc., Carterra Inc., AMETEK, Inc., Bristol Myers Squibb, Horiba, Ltd., and Bruker. Bio-Rad Laboratories holds leading position in the global market due to strong expertise in developing high throughput analyzers used clinical research and drug discovery studies. Bristol Myers Squibb and Biosensing Instrument Inc. are also actively engaged in developing more sensitive SPR biosensors systems for early stage disease diagnosis. Carterra Inc. provides advanced plasmonic biosensing solutions optimized for label-free biomarker detection to support drug development.
Comments
Post a Comment